SRXH

$0.15

Market ClosedAs of Mar 17, 8:00 PM UTC

SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.15
Potential Upside
5%
Whystock Fair Value$0.16
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorConsumer Defensive
IndustryPackaged Foods

SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally. The company offers pet health and wellness products in multiple forms, in...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$45.18M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.69

Recent News

TipRanks
Feb 7, 2026

Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results

As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 23, 2026

A Look At Opendoor Technologies (OPEN) Valuation As New Stake And Policy Support Refocus Investor Attention

Recent investor interest in Opendoor Technologies (OPEN) has picked up after SRx Health Solutions disclosed a new stake, just as the CEO publicly backed President Trump’s executive order curbing institutional purchases of single-family homes. See our latest analysis for Opendoor Technologies. Those headlines have arrived after a sharp run in Opendoor’s total shareholder return, which is very large over the past year. At the same time, the 90 day share price return of 19.45% and a recent 1 day...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 23, 2026

How Investors Are Reacting To Opendoor Technologies (OPEN) After SRx Stake And CEO’s Housing Policy Support

In recent weeks, Opendoor Technologies has drawn attention as SRx Health disclosed a new position in the company and CEO Max Nejatian publicly backed President Trump’s executive order limiting large institutional purchases of single-family homes. This combination of an outside investor signaling confidence and a policy stance aligned with Opendoor’s focus on individual homebuyers adds a fresh angle to how the company is perceived in the housing market. With SRx Health’s investment as a focal...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Jan 16, 2026

Why Is Opendoor (OPEN) Stock Rocketing Higher Today

Shares of technology real estate company Opendoor (NASDAQ:OPEN) jumped 5.9% in the afternoon session after SRx Health Solutions announced it invested in the residential real estate technology company, viewing its shares as undervalued.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barchart
Dec 17, 2025

This Little-Known Penny Stock Is Surging on Digital Asset Treasury News. Should You Buy Shares Here?

SRx Health stock soars as the company announces a major crypto pivot. But investors are cautioned against chasing the momentum in SRXH shares heading into 2026.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.